We have performed a differential expression analysis comparing SERPINA3 and key GAM markers between glioma samples and non-tumor tissues from the databases, which confirmed significant upregulation of SERPINA3 and GAM markers in both LGG and GBM tumors compared to normal tissues (Fig. S1). This evidence concerns the gene GLS and central nervous system cancer.